Friedreich Ataxia Scientific News

Friedreich Ataxia and close related scientific news. Topics related to rare diseases.

Friday, September 27, 2024

ASSAIGS CLÍNICS I REVISIÓ FARMACOLÒGICA DE L’ATÀXIA DE FRIEDREICH

›
Treball Final de Grau Grau de Farmàcia ASSAIGS CLÍNICS I REVISIÓ FARMACOLÒGICA.NÚRIA BAIGES BEGUER. Facultat de Farmàcia i Ciències de l’A...

Case Report of Friedreich's Ataxia and ALG1-Related Biochemical Abnormalities in a Patient With Progressive Spastic Paraplegia

›
Quinlan, A., Rodan, L., Barkoudah, E., Tam, A., Saffari, A., Shammas, I., Ranatunga, W., Morava-Kozicz, E., Oglesbee, D., Berry, G., Ebrahim...
Monday, September 23, 2024

VIDEOFLUOROSCOPIC SWALLOWING STUDY FINDINGS AND RESPIRATORY FUNCTION TESTING IN PATIENTS WITH FRIEDREICH ATAXIA

›
VIDEOFLUOROSCOPIC SWALLOWING STUDY FINDINGS AND RESPIRATORY FUNCTION TESTING IN PATIENTS WITH FRIEDREICH ATAXIA. LEON ASTUDILLO, CARMEN E et...
Wednesday, September 18, 2024

Early Genetic Testing Avoids Treatment Delays for Patients with Friedreich Ataxia

›
EMJ. 2024;9[3]:14-23. doi:10.33590/emj/RSCJ7037  This industry-sponsored symposium took place during the European Association of Neurology (...
Tuesday, September 17, 2024

Papillon Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich's Ataxia

›
SAN DIEGO--(BUSINESS WIRE)--Sep 17, 2024-- Papillon Therapeutics Inc., today announced that the U.S. Food and Drug Administration (FDA) ha...

Mitotech Presents Promising Results in Friedreich's Ataxia

›
LONDON, Sept. 17, 2024 /PRNewswire-PRWeb/ -- Mitotech Ltd, a mitochondria-focused clinical-stage biotechnology company, presented new data f...
Saturday, September 14, 2024

Skeletal Muscle Involvement in Friedreich Ataxia

›
Indelicato, E.; Wanschitz, J.; Löscher, W.; Boesch, S. Skeletal Muscle Involvement in Friedreich Ataxia. Int. J. Mol. Sci. 2024, 25, 9915. d...
Tuesday, September 10, 2024

Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1/AMPK, KEAP1, and GSK3β in the impairment of the NRF2 response

›
Arabela Sanz-Alcázar, Marta Portillo-Carrasquer, Fabien Delaspre, Maria Pazos-Gil, Jordi Tamarit, Joaquim Ros, Elisa Cabiscol, Deciphering t...
Monday, September 9, 2024

Unusual Age-Dependent Behavior of Leukocytes Telomere Length in Friedreich's Ataxia

›
Scarabino D, Veneziano L, Nethisinghe S, Mantuano E, Fiore A, Granata G, Solanky N, Zanni G, Cavalcanti F, Corbo RM, Giunti P. Unusual Age-D...

A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients

›
Paparella, G.; Stragà, C.; Pesenti, N.; Dal Molin, V.; Martorel, G.A.; Merotto, V.; Genova, C.; Piazza, A.; Piccoli, G.; Panzeri, E.; et al....
‹
›
Home
View web version

About Me

My photo
Juan Carlos Baiges
Tortosa, Catalunya, Spain
BSc, MSc (Pharmacy), MSc (Computer science)
View my complete profile
Powered by Blogger.